Remove Clinical Research Remove Drug Trials Remove Pharmacokinetics Remove Regulations
article thumbnail

What are the top disease areas for clinical drug trials?

Drug Discovery World

AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone was approved in the EU for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men for whom chemotherapy is not clinically indicated. The post What are the top disease areas for clinical drug trials?

Trials 130
article thumbnail

How Improving Diversity Can Benefit Clinical Trials

Alta Sciences

Regulatory organizations like Health Canada, the International Council for Harmonisation (ICH), and the European Medicines Agency (EMA) have long emphasized the importance of including diverse populations in clinical research. Discover how drug developers, researchers, and regulators are ensuring this happens.